The overall prognosis of thyroid cancer is excellent, but some patients have grossly invasive disease and distant metastases with limited responses to systemic therapies. Thus, relevant preclinical models are needed to investigate thyroid cancer biology and novel treatments. Different preclinical models have recently emerged with advances in thyroid cancer genetics, mouse modeling and new cell lines. Choosing the appropriate model according to the research question is crucial to studying thyroid cancer. This review will discuss the current preclinical models frequently used in thyroid cancer research, from cell lines to mouse models, and future perspectives on patient-derived and humanized preclinical models in this field.
Citations
Citations to this article as recorded by
Advancements of 3D bioprinting in regenerative medicine: Exploring cell sources for organ fabrication Yue Ma, Bo Deng, Runbang He, Pengyu Huang Heliyon.2024; 10(3): e24593. CrossRef
Strategies to investigate migration and metastases in thyroid cancer Daniel M. Chopyk, Priya H. Dedhia Current Opinion in Endocrine and Metabolic Research.2024; 34: 100502. CrossRef
Mouse Models to Examine Differentiated Thyroid Cancer Pathogenesis: Recent Updates Hye Choi, Kwangsoon Kim International Journal of Molecular Sciences.2023; 24(13): 11138. CrossRef
Modeling the tumor microenvironment of anaplastic thyroid cancer: an orthotopic tumor model in C57BL/6 mice Zhen Xu, Hyo Shik Shin, Yoo Hyung Kim, Seong Yun Ha, Jae-Kyung Won, Su-jin Kim, Young Joo Park, Sareh Parangi, Sun Wook Cho, Kyu Eun Lee Frontiers in Immunology.2023;[Epub] CrossRef
Patient-derived tumor models: a suitable tool for preclinical studies on esophageal cancer Fan Liang, Hongyan Xu, Hongwei Cheng, Yabo Zhao, Junhe Zhang Cancer Gene Therapy.2023; 30(11): 1443. CrossRef
Mechanistic Insights of Thyroid Cancer Progression Luis Javier Leandro-García, Iñigo Landa Endocrinology.2023;[Epub] CrossRef
Advances of Osteosarcoma Models for Drug Discovery and Precision Medicine Linyun Tan, Yitian Wang, Xin Hu, Guifeng Du, Xiaodi Tang, Li Min Biomolecules.2023; 13(9): 1362. CrossRef